‘Safe Drug Sites’ Haven’t Failed. Federal Policy Has

Supervised consumption sites have become a flashpoint in the debate over how to address the opioid crisis, often framed in stark terms of success or failure. But the evidence tells a more complicated story: these sites are neither a panacea nor a proven failure, and evaluating them requires a clearer understanding of scale, access, and policy constraints.